Drugs Judged Harmful in Advanced Nations Still Circulating in Korea

[Guest guest]

To think that drugs finally banned in the States and Britain could still be

causing trouble for other people.

Drugs Judged Harmful in Advanced Nations Still Circulating in Korea

AUGUST 05, 2004 22:07

by Seung-Heon Lee (ddr@...)

Following the recent decision to suspend sales of 166 drugs for colds with

phenylpropanolamine (PPA), which can cause strokes, shockwaves are resounding

across the nation as the government admitted that several medicines with

ingredients judged to be harmful in advanced nations are still being sold within

the nation.

It seems that the revelation of the government’s negligence to act on the

distribution of yet another drug suspected to be harmful, on the top of its late

action against medicine with PPA, will add to the public’s anger.

On the morning of August 5 at a meeting between the ruling Uri Party and

the Ministry of Health and Welfare, the Korea Food and Drug Association

“admitted it was true that medicine containing ingredients like PPA, harmful

according to the standard of advanced nations such as the U.S., though their

harmful effects have yet to be proved, are still in circulation within the

nation, as the Uri Party claimed,” according to Uri Party member Lee Mok-hee.

Lee added, “KFDA will explain to the public in detail about the drugs in

question after thorough investigations. If the products are found to be harmful

through clinical research, sales can be suspended immediately.” Regarding the

issue, the party and the government agency, in fear of causing turmoil within

the public, did not reveal the products with the suspicious materials and only

disclosed some of the suspected components such as “sulpyrine” and “ampoule

injection materials.”

However, in a press release issued this day, the Korea Consumer Protection

Board and Ko Kyung-hwa, a GNP lawmaker on the National Assembly’s Health and

Welfare Committee, pointed out that medicines containing terpenadine, pemoline,

nandrolone, metamizol sodium, nefazodone, and naftidro-furyl infusion were also

available in the market unlike the U.S. It has become known that the Korea

Consumer Protection Board alerted the KFDA of these facts in May, but the

administration dismissed the warnings saying, “All medicines come with

potentially harmful effects.”

Meanwhile, the Uri Party cited there was a fundamental problem with the

KFDA’s drug management system and pushed for the introduction of the Drug

Utilization Review, which identifies drugs which may show adverse effects when

used with other drugs, and for the systemization of a drug recall system.

[Guest guest]

To think that drugs finally banned in the States and Britain could still be

causing trouble for other people.

Drugs Judged Harmful in Advanced Nations Still Circulating in Korea

AUGUST 05, 2004 22:07

by Seung-Heon Lee (ddr@...)

Following the recent decision to suspend sales of 166 drugs for colds with

phenylpropanolamine (PPA), which can cause strokes, shockwaves are resounding

across the nation as the government admitted that several medicines with

ingredients judged to be harmful in advanced nations are still being sold within

the nation.

It seems that the revelation of the government’s negligence to act on the

distribution of yet another drug suspected to be harmful, on the top of its late

action against medicine with PPA, will add to the public’s anger.

On the morning of August 5 at a meeting between the ruling Uri Party and

the Ministry of Health and Welfare, the Korea Food and Drug Association

“admitted it was true that medicine containing ingredients like PPA, harmful

according to the standard of advanced nations such as the U.S., though their

harmful effects have yet to be proved, are still in circulation within the

nation, as the Uri Party claimed,” according to Uri Party member Lee Mok-hee.

Lee added, “KFDA will explain to the public in detail about the drugs in

question after thorough investigations. If the products are found to be harmful

through clinical research, sales can be suspended immediately.” Regarding the

issue, the party and the government agency, in fear of causing turmoil within

the public, did not reveal the products with the suspicious materials and only

disclosed some of the suspected components such as “sulpyrine” and “ampoule

injection materials.”

However, in a press release issued this day, the Korea Consumer Protection

Board and Ko Kyung-hwa, a GNP lawmaker on the National Assembly’s Health and

Welfare Committee, pointed out that medicines containing terpenadine, pemoline,

nandrolone, metamizol sodium, nefazodone, and naftidro-furyl infusion were also

available in the market unlike the U.S. It has become known that the Korea

Consumer Protection Board alerted the KFDA of these facts in May, but the

administration dismissed the warnings saying, “All medicines come with

potentially harmful effects.”

Meanwhile, the Uri Party cited there was a fundamental problem with the

KFDA’s drug management system and pushed for the introduction of the Drug

Utilization Review, which identifies drugs which may show adverse effects when

used with other drugs, and for the systemization of a drug recall system.

[Guest guest]

To think that drugs finally banned in the States and Britain could still be

causing trouble for other people.

Drugs Judged Harmful in Advanced Nations Still Circulating in Korea

AUGUST 05, 2004 22:07

by Seung-Heon Lee (ddr@...)

Following the recent decision to suspend sales of 166 drugs for colds with

phenylpropanolamine (PPA), which can cause strokes, shockwaves are resounding

across the nation as the government admitted that several medicines with

ingredients judged to be harmful in advanced nations are still being sold within

the nation.

It seems that the revelation of the government’s negligence to act on the

distribution of yet another drug suspected to be harmful, on the top of its late

action against medicine with PPA, will add to the public’s anger.

On the morning of August 5 at a meeting between the ruling Uri Party and

the Ministry of Health and Welfare, the Korea Food and Drug Association

“admitted it was true that medicine containing ingredients like PPA, harmful

according to the standard of advanced nations such as the U.S., though their

harmful effects have yet to be proved, are still in circulation within the

nation, as the Uri Party claimed,” according to Uri Party member Lee Mok-hee.

Lee added, “KFDA will explain to the public in detail about the drugs in

question after thorough investigations. If the products are found to be harmful

through clinical research, sales can be suspended immediately.” Regarding the

issue, the party and the government agency, in fear of causing turmoil within

the public, did not reveal the products with the suspicious materials and only

disclosed some of the suspected components such as “sulpyrine” and “ampoule

injection materials.”

However, in a press release issued this day, the Korea Consumer Protection

Board and Ko Kyung-hwa, a GNP lawmaker on the National Assembly’s Health and

Welfare Committee, pointed out that medicines containing terpenadine, pemoline,

nandrolone, metamizol sodium, nefazodone, and naftidro-furyl infusion were also

available in the market unlike the U.S. It has become known that the Korea

Consumer Protection Board alerted the KFDA of these facts in May, but the

administration dismissed the warnings saying, “All medicines come with

potentially harmful effects.”

Meanwhile, the Uri Party cited there was a fundamental problem with the

KFDA’s drug management system and pushed for the introduction of the Drug

Utilization Review, which identifies drugs which may show adverse effects when

used with other drugs, and for the systemization of a drug recall system.

[Guest guest]

To think that drugs finally banned in the States and Britain could still be

causing trouble for other people.

Drugs Judged Harmful in Advanced Nations Still Circulating in Korea

AUGUST 05, 2004 22:07

by Seung-Heon Lee (ddr@...)

Following the recent decision to suspend sales of 166 drugs for colds with

phenylpropanolamine (PPA), which can cause strokes, shockwaves are resounding

across the nation as the government admitted that several medicines with

ingredients judged to be harmful in advanced nations are still being sold within

the nation.

It seems that the revelation of the government’s negligence to act on the

distribution of yet another drug suspected to be harmful, on the top of its late

action against medicine with PPA, will add to the public’s anger.

On the morning of August 5 at a meeting between the ruling Uri Party and

the Ministry of Health and Welfare, the Korea Food and Drug Association

“admitted it was true that medicine containing ingredients like PPA, harmful

according to the standard of advanced nations such as the U.S., though their

harmful effects have yet to be proved, are still in circulation within the

nation, as the Uri Party claimed,” according to Uri Party member Lee Mok-hee.

Lee added, “KFDA will explain to the public in detail about the drugs in

question after thorough investigations. If the products are found to be harmful

through clinical research, sales can be suspended immediately.” Regarding the

issue, the party and the government agency, in fear of causing turmoil within

the public, did not reveal the products with the suspicious materials and only

disclosed some of the suspected components such as “sulpyrine” and “ampoule

injection materials.”

However, in a press release issued this day, the Korea Consumer Protection

Board and Ko Kyung-hwa, a GNP lawmaker on the National Assembly’s Health and

Welfare Committee, pointed out that medicines containing terpenadine, pemoline,

nandrolone, metamizol sodium, nefazodone, and naftidro-furyl infusion were also

available in the market unlike the U.S. It has become known that the Korea

Consumer Protection Board alerted the KFDA of these facts in May, but the

administration dismissed the warnings saying, “All medicines come with

potentially harmful effects.”

Meanwhile, the Uri Party cited there was a fundamental problem with the

KFDA’s drug management system and pushed for the introduction of the Drug

Utilization Review, which identifies drugs which may show adverse effects when

used with other drugs, and for the systemization of a drug recall system.